Felicia Cosman
West Haverstraw, NYNPI 1285766063
Payments from drug & device makers
$1,611,720in general payments, 2019–2025
Across 1,216 payments — averaging $1325.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1.1M
- Radius Health, Inc.$433K
- Pfizer$24K
- UCB SA$13K
- Myovant Sciences Inc.$2K
- Lilly USA, LLC$2K
- plus $603 from 1 others
$46,241in research payments, 2019–2025
Across 20 payments — averaging $2312.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$40K
- Radius Health, Inc.$6K
- Biocon Biologics Inc$600
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 742 | $1,137,955 |
| Radius Health, Inc. | 455 | $432,519 |
| Pfizer | 8 | $23,534 |
| UCB SA | 7 | $13,143 |
| Myovant Sciences Inc. | 2 | $2,167 |
| Lilly USA, LLC | 1 | $1,800 |
| Organon | 1 | $603 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.